Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Income from Continuing Operations (2016 - 2025)

HealthLynked (HLYK) has disclosed Income from Continuing Operations for 10 consecutive years, with 736654.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 62.67% to 736654.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 3581005.0, a 42.12% increase, with the full-year FY2024 number at 6131479.0, down 69.66% from a year prior.
  • Income from Continuing Operations was 736654.0 for Q3 2025 at HealthLynked, down from 682780.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 161370.0 in Q3 2023 to a low of 7823453.0 in Q1 2021.
  • A 5-year average of 1624418.37 and a median of 1230206.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 1248.37% in 2021, then skyrocketed 89.49% in 2023.
  • HealthLynked's Income from Continuing Operations stood at 2003004.0 in 2021, then tumbled by 103.55% to 4077090.0 in 2022, then skyrocketed by 68.46% to 1285733.0 in 2023, then increased by 4.32% to 1230206.0 in 2024, then skyrocketed by 40.12% to 736654.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Income from Continuing Operations are 736654.0 (Q3 2025), 682780.0 (Q2 2025), and 931365.0 (Q1 2025).